SITC 29th Annual Meeting: Adoptive ImmunotherapyNovember 7-9, 2014 Gaylord National Hotel & Convention Center National Harbor, MDProgram Session Co-ChairsHelen E. Heslop, MD – Baylor College of Medicine Per thor Straten, PhD – Centre for Cancer Immune Therapy (CCIT) SITC 29th Annual Meeting OrganizersArthur A. Hurwitz, PhD - National Cancer Institute Kim A. Margolin, MD - Stanford University Daniel E. Speiser, MD - Ludwig Center for Cancer Research of the University of Lausanne Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer CenterProgram SummaryFrom the Society for Immunotherapy of Cancer (SITC), these enduring materials from the SITC 29th Annual Meeting (2014): Adoptive Immunotherapy on November 7, 2014 in National Harbor, MD focus on two cell types, tumor infiltrating lymphocytes (TILs) and T cells genetically modified with chimeric antigen receptors (CARs) that have progressed to late phase studies. Two presentations focused on TILs addressing how biomarkers can be used to characterize the cell product and monitor responses and describing clinical results from an ongoing European phase III trial, as well as discuss possible ways to improve response rates. In addition, two other presentations reviewed clinical experience with CAR-transduced T cells in the clinic and discuss #Biomarkers #ClinicalTrials #ColorectalCancer #GastrointestinalCancers #Leukemia #Melanoma #PresentationSlides #Video#AnnualMeeting #SITC #Clinician #Industry #Oncologist #Researcher #2014 #AdoptiveCellTherapy
Meeting: SITC 29th Annual Meeting; Session: Adoptive Immunotherapy; Presentation: Toward Cell Transfer Immunotherapy Against Patient-Specific Mutations in Gastrointestinal Cancers; Presenter: Eric Tran, PhD – National Insitutes of Health/National Cancer Institute; Date: November 8, 201400:15:54
Meeting: SITC 29th Annual Meeting; Session: Adoptive Immunotherapy; Presentation: Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer; Presenter: Madhusudhanan Sukumar, PhD – National Cancer Institute; Date: November 8, 201400:14:28
Meeting: SITC 29th Annual Meeting; Session: Adoptive Immunotherapy; Presentation: Enhancing the IQ of CAR T Cells; Presenter: Michael C.V. Jensen, MD – University of Washington; Date: November 8, 201400:26:33
Meeting: SITC 29th Annual Meeting; Session: Adoptive Immunotherapy; Presentation: Moving Tumor Infiltrating Lymphocytes and Biomarkers Forward; Presenter: Patrick Hwu, MD – University of Texas, MD Anderson Cancer Center; Date: November 8, 201400:25:12
Meeting: SITC 29th Annual Meeting; Session: Adoptive Immunotherapy; Presentation: Melanoma Therapy using Adoptive Transfer of Expanded Tumor Infiltrating T cells; Prospects and Pitfalls; Presenter: Per thor Straten, PhD – Centre for Cancer Immune Therapy (CCIT); Date: November 8, 201400:28:15